Back to Journals » Drug Design, Development and Therapy » Volume 13
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
18,436 | Dovepress* | 13,626+ | 1,676 | 15,302 | |
PubMed Central* | 4,810 | 1,215 | 6,025 | ||
Totals | 18,436 | 2,891 | 21,327 | ||
*Since 17 April 2019 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar